Skip to main content
Erschienen in: International Urogynecology Journal 12/2016

16.06.2016 | Original Article

Postoperative appointments: which ones count?

verfasst von: Margaret G. Mueller, Dana Elborno, Bhumy A. Davé, Alix Leader-Cramer, Christina Lewicky-Gaupp, Kimberly Kenton

Erschienen in: International Urogynecology Journal | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Although postoperative complications in women undergoing reconstructive pelvic surgery (RPS) have been characterized, little is known regarding the timeline of these occurrences. We aimed to determine the timeframe after RPS during which the majority of complications occur, to assist with planning intervals between postoperative visits.

Methods

Women undergoing RPS were identified through billing information. Demographic, surgical, and complications data were extracted from electronic medical records.
The Pelvic Floor Complication scale is a surgical scale tailored to women undergoing RPS. It contains three subscales: intraoperative, immediately postoperative, and delayed complications. We applied this scale to each postoperative visit (at 2, 6, and 13 weeks).

Results

396 women underwent RPS and 125 patients had 179 complications, most of which (66 %) were identified by the 2-week visit. Complications at the 2-week visit consisted of urinary tract infection (UTI; 46 %), wound infection (10.0 %), and urinary retention (9.4 %). The majority of serious complications (venous thromboembolism [VTE], ileus, small bowel obstruction [SBO], readmission, and reoperation [1 incarcerated hernia and 1 sling release]) were diagnosed by 2 weeks. One patient was readmitted for ileus at between 2 and 6 weeks. At between 6 and 13 weeks, 1 patient was readmitted with SBO; 1 VTE was diagnosed; and 1 required reoperation for a prolapsed fallopian tube. In contrast, two thirds of the complications seen at the 13-week visit were due to granulation tissue, suture erosion or mesh erosion.

Conclusions

The majority of non-mesh-related complications occur within the first 2 weeks after RPS, whereas mesh and suture complications are more likely to be identified at the 13-week visit.
Literatur
1.
Zurück zum Zitat Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B (2014) Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol 211(5):547.e1–547.e8CrossRef Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B (2014) Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol 211(5):547.e1–547.e8CrossRef
2.
Zurück zum Zitat Unger CA, Walters MD, Ridgeway B, Jelovsek JE, Barber MD, Paraiso MF (2015) Incidence of adverse events after uterosacral colpopexy for uterovaginal and posthysterectomy vault prolapse. Am J Obstet Gynecol 212(5):603.e1–603.e7CrossRef Unger CA, Walters MD, Ridgeway B, Jelovsek JE, Barber MD, Paraiso MF (2015) Incidence of adverse events after uterosacral colpopexy for uterovaginal and posthysterectomy vault prolapse. Am J Obstet Gynecol 212(5):603.e1–603.e7CrossRef
3.
Zurück zum Zitat Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M et al (2013) Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA: J Am Med Assoc 309(19):2016–2024CrossRef Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M et al (2013) Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA: J Am Med Assoc 309(19):2016–2024CrossRef
4.
Zurück zum Zitat Mueller MG (2016) When do we see our postoperative patients? Am J Obstet Gynecol 214(4):S505–S506CrossRef Mueller MG (2016) When do we see our postoperative patients? Am J Obstet Gynecol 214(4):S505–S506CrossRef
5.
Zurück zum Zitat Woelk JL, Borah BJ, Trabuco EC, Heien HC, Gebhart JB (2014) Cost differences among robotic, vaginal, and abdominal hysterectomy. Obstet Gynecol 123(2 Pt 1):255–262CrossRefPubMedPubMedCentral Woelk JL, Borah BJ, Trabuco EC, Heien HC, Gebhart JB (2014) Cost differences among robotic, vaginal, and abdominal hysterectomy. Obstet Gynecol 123(2 Pt 1):255–262CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Scott AR, Rush AJ 3rd, Naik AD, Berger DH, Suliburk JW (2015) Surgical follow-up costs disproportionately impact low-income patients. J Surg Res 199(1):32–38CrossRefPubMed Scott AR, Rush AJ 3rd, Naik AD, Berger DH, Suliburk JW (2015) Surgical follow-up costs disproportionately impact low-income patients. J Surg Res 199(1):32–38CrossRefPubMed
7.
Zurück zum Zitat Committee on Practice Bulletins—Gynecology ACoO, Gynecologists (2007) ACOG Practice Bulletin no. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 110(2 Pt 1):429–440 Committee on Practice Bulletins—Gynecology ACoO, Gynecologists (2007) ACOG Practice Bulletin no. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 110(2 Pt 1):429–440
8.
Zurück zum Zitat Bulletins—Gynecology ACoP (2009) ACOG Practice Bulletin no. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 113(5):1180–1189 Bulletins—Gynecology ACoP (2009) ACOG Practice Bulletin no. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 113(5):1180–1189
9.
Zurück zum Zitat Gutman RE, Nygaard IE, Ye W, Rahn DD, Barber MD, Zyczynski HM et al (2013) The Pelvic Floor Complication Scale: a new instrument for reconstructive pelvic surgery. Am J Obstet Gynecol 208(1):81.e1–81.e9CrossRef Gutman RE, Nygaard IE, Ye W, Rahn DD, Barber MD, Zyczynski HM et al (2013) The Pelvic Floor Complication Scale: a new instrument for reconstructive pelvic surgery. Am J Obstet Gynecol 208(1):81.e1–81.e9CrossRef
10.
Zurück zum Zitat Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL et al (2011) Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol 205(5):498.e1–498.e6CrossRef Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL et al (2011) Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol 205(5):498.e1–498.e6CrossRef
11.
Zurück zum Zitat Brubaker L, Cundiff GW, Fine P, Nygaard I, Richter HE, Visco AG et al (2006) Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med 354(15):1557–1566CrossRefPubMed Brubaker L, Cundiff GW, Fine P, Nygaard I, Richter HE, Visco AG et al (2006) Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med 354(15):1557–1566CrossRefPubMed
12.
Zurück zum Zitat Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE et al (2007) Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356(21):2143–2155CrossRefPubMed Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE et al (2007) Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356(21):2143–2155CrossRefPubMed
13.
Zurück zum Zitat Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT et al (2010) Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 362(22):2066–2076CrossRefPubMedPubMedCentral Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT et al (2010) Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 362(22):2066–2076CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD, Kenton K et al (2012) A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med 366(25):2358–2367CrossRefPubMedPubMedCentral Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD, Kenton K et al (2012) A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med 366(25):2358–2367CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Barber MD, Brubaker L, Burgio KL, Richter HE, Nygaard I, Weidner AC et al (2014) Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA 311(10):1023–1034CrossRefPubMedPubMedCentral Barber MD, Brubaker L, Burgio KL, Richter HE, Nygaard I, Weidner AC et al (2014) Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA 311(10):1023–1034CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM (2010) Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J 21(8):955–961CrossRefPubMed Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM (2010) Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J 21(8):955–961CrossRefPubMed
17.
Zurück zum Zitat Solomon ER, Frick AC, Paraiso MF, Barber MD (2010) Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. Am J Obstet Gynecol 203(5):510.e1–510.e4CrossRef Solomon ER, Frick AC, Paraiso MF, Barber MD (2010) Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. Am J Obstet Gynecol 203(5):510.e1–510.e4CrossRef
18.
Zurück zum Zitat Burgio KL, Brubaker L, Richter HE, Wai CY, Litman HJ, France DB et al (2010) Patient satisfaction with stress incontinence surgery. Neurourol Urodyn 29(8):1403–1409CrossRefPubMedPubMedCentral Burgio KL, Brubaker L, Richter HE, Wai CY, Litman HJ, France DB et al (2010) Patient satisfaction with stress incontinence surgery. Neurourol Urodyn 29(8):1403–1409CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Wolters JP, King AB, Rapp DE (2014) Satisfaction in patients undergoing concurrent pelvic floor surgery for stress urinary incontinence and pelvic organ prolapse. Female Pelvic Med Reconstr Surg 20(1):23–26CrossRefPubMed Wolters JP, King AB, Rapp DE (2014) Satisfaction in patients undergoing concurrent pelvic floor surgery for stress urinary incontinence and pelvic organ prolapse. Female Pelvic Med Reconstr Surg 20(1):23–26CrossRefPubMed
20.
Zurück zum Zitat Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194(3):722–728CrossRefPubMed Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194(3):722–728CrossRefPubMed
21.
Zurück zum Zitat Lowenstein L, FitzGerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER et al (2008) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 19(1):81–84CrossRefPubMed Lowenstein L, FitzGerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER et al (2008) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 19(1):81–84CrossRefPubMed
Metadaten
Titel
Postoperative appointments: which ones count?
verfasst von
Margaret G. Mueller
Dana Elborno
Bhumy A. Davé
Alix Leader-Cramer
Christina Lewicky-Gaupp
Kimberly Kenton
Publikationsdatum
16.06.2016
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 12/2016
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-016-3052-2

Weitere Artikel der Ausgabe 12/2016

International Urogynecology Journal 12/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.